Biomarker-guided trial designs (BiGTeD):
An online tool to help develop personalised medicine
Subgroup Specific Designs
This strategy is an approach to analyze a biomarker-stratified trial.
Both biomarker-positive and biomarker-negative subgroups can be tested in a sequential or in a parallel way.
Sequential Subgroup-Specific Designs
Parallel Subgroup Specific Designs
BiGTED is funded by the Medical Research Council
To find out more please contact us by E-Mailing